Name | Number of supported studies | Average coverage | |
---|---|---|---|
squamous epithelial cell | 4 studies | 29% ± 11% |
Insufficient scRNA-seq data for expression of GDPD3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 99% | 902.34 | 958 / 966 | 96% | 13.57 | 505 / 527 |
uterus | 100% | 981.39 | 170 / 170 | 95% | 15.67 | 434 / 459 |
bladder | 100% | 524.00 | 21 / 21 | 94% | 36.18 | 474 / 504 |
stomach | 95% | 468.01 | 341 / 359 | 92% | 10.22 | 264 / 286 |
esophagus | 97% | 1231.01 | 1405 / 1445 | 87% | 9.24 | 160 / 183 |
ovary | 97% | 694.59 | 175 / 180 | 86% | 6.54 | 371 / 430 |
lung | 98% | 651.01 | 566 / 578 | 84% | 7.41 | 974 / 1155 |
breast | 100% | 560.83 | 458 / 459 | 80% | 11.35 | 892 / 1118 |
kidney | 100% | 582.79 | 89 / 89 | 65% | 4.28 | 585 / 901 |
thymus | 99% | 521.81 | 645 / 653 | 57% | 2.50 | 342 / 605 |
brain | 68% | 242.36 | 1808 / 2642 | 85% | 4.16 | 596 / 705 |
prostate | 99% | 676.74 | 243 / 245 | 53% | 2.11 | 265 / 502 |
adrenal gland | 83% | 207.91 | 213 / 258 | 56% | 2.34 | 128 / 230 |
skin | 91% | 538.89 | 1648 / 1809 | 47% | 2.34 | 221 / 472 |
pancreas | 23% | 48.55 | 75 / 328 | 96% | 16.26 | 171 / 178 |
spleen | 100% | 955.72 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.32 | 1 / 1 |
adipose | 99% | 686.21 | 1193 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 96% | 397.92 | 1281 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 4.99 | 27 / 29 |
tonsil | 0% | 0 | 0 / 0 | 89% | 8.57 | 40 / 45 |
peripheral blood | 89% | 502.78 | 823 / 929 | 0% | 0 | 0 / 0 |
heart | 82% | 269.35 | 709 / 861 | 0% | 0 | 0 / 0 |
liver | 45% | 82.84 | 101 / 226 | 26% | 1.57 | 105 / 406 |
muscle | 46% | 87.10 | 368 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 9% | 0.23 | 7 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0034638 | Biological process | phosphatidylcholine catabolic process |
GO_0070291 | Biological process | N-acylethanolamine metabolic process |
GO_0046475 | Biological process | glycerophospholipid catabolic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0004622 | Molecular function | lysophospholipase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0008081 | Molecular function | phosphoric diester hydrolase activity |
Gene name | GDPD3 |
Protein name | Lysophospholipase D GDPD3 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 7) (Glycerophosphodiester phosphodiesterase domain-containing protein 3) Glycerophosphodiester phosphodiesterase domain containing 3 |
Synonyms | GDE7 |
Description | FUNCTION: Hydrolyzes lysoglycerophospholipids to produce lysophosphatidic acid (LPA) and the corresponding amines . Shows a preference for 1-O-alkyl-sn-glycero-3-phosphocholine (lyso-PAF), lysophosphatidylcholine (lyso-PC) and N-acylethanolamine lysophospholipids . Does not display glycerophosphodiester phosphodiesterase activity, since it cannot hydrolyze either glycerophosphoinositol or glycerophosphocholine. . |
Accessions | Q7L5L3 ENST00000566613.1 H3BPX3 ENST00000406256.8 [Q7L5L3-2] ENST00000566434.5 H3BMN9 |